Galmed Pharmaceuticals (EOCN) Income towards Parent Company (2013 - 2026)
Galmed Pharmaceuticals (EOCN) recorded Income towards Parent Company of $2.72 million in Q2 2026, up 9.1% from $2.5 million a year earlier.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Income towards Parent Company (2013 - 2026) Analysis & Trends
On a TTM basis, Galmed Pharmaceuticals' Income towards Parent Company came in at -$3.1 million as of Jun 30, 2026; for FY2025, it came in at -$316,000.
- Across earlier years, Income towards Parent Company came in at -$378,000 in FY2024, $6.91 million in FY2023 (-61.3%), $17.87 million in FY2022 (-45.0%) and $32.47 million in FY2021 (+12.8%).
- The Q2 2026 figure is the highest quarterly Income towards Parent Company since Q3 2022.
- On a year-over-year basis, Income towards Parent Company rose in three of the last four quarters, with growth averaging 40.2%.
- Peak year-over-year performance for Income towards Parent Company in the last five years was growth of 123.0% in Q2 2025, against a decline of 72.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$1.91 million (Q1 2026), -$5.81 million (Q4 2025) and $1.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Galmed Pharmaceuticals | 420,034.32 | 420,034.32 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Mn |
| Mar 31, 2026 | -1.91 Mn |
| Dec 31, 2025 | -5.81 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | -4.69 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | -1.83 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Sep 30, 2022 | 5.35 Mn |
| Jun 30, 2022 | 3.73 Mn |
| Mar 31, 2022 | -6.14 Mn |
| Dec 31, 2021 | 7.45 Mn |
| Sep 30, 2021 | 7.71 Mn |
API Access
Galmed Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();